FEATURE STORY
● Artificial intelligence approach to create AAV capsids for gene therapies
DISRUPTIVE TECHNOLOGIES
● Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier
CLINICAL TRIALS – DATAS
● Libella gene therapeutics to run a patient paid trial of telomerase gene therapy
M&A – AGREEMENTS
● Novartis to acquire The Medicines Company for USD 9.7bn, adding inclisiran
INVESTMENTS – FUNDRAISINGS
● Ferring and Blackstone Life Sciences invest over $570 Million USD in novel gene therapy for bladder cancer patients
● Two Chinese companies invest in Vigeneron, a German firm developing ophthalmological gene therapy programs
● Vertex is planning a major expansion in the Seaport
●Thermo Fisher Scientific unveils $6 Million expansion at viral vector manufacturing facility
●$50M cell and viral vector manufacturing operation backed by Harvard
MISCELLANEOUS
● FDA issues guidance for industry on adaptive designs for clinical trials of drugs and biologics
To read the full articles, click here: Trend Chart on Innovative BioIndustries – December 3rd
COMMENTS ARE OFF THIS POST